POSITION：HOME > Pharmaceutical Catalogue > Selpercatinib > Selpercatinib Drug News
Selpercatinib
Selpercatinib

Selpercatinib (Retevmo,Sepadx)

Selpercatinib is a highly selective and potent kinase inhibitor that exerts its therapeutic effect by selectively targeting and inhibiting mutated or fusion forms of the RET gene.

  • 40mg*120capsules

WhatsApp

To ensure medication safety, consult customer service for free before purchasing. Returns/exchanges are not accepted except for quality issues.
Authentic
Guarantee
Fast Delivery
Privacy